000			01958 a2200589 4500
005			20250513170729.0
264		0	_c19990311
008			199903s 0 0 eng d
022			_a0041-1337
024	7		_a10.1097/00007890-199901270-00011 _2doi
040			_aNLM _beng _cNLM
100	1		_aVallhonrat, H
245	0	0	_aIn vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients. _h[electronic resource]
260			_bTransplantation _cJan 1999
300			_a253-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBlood Pressure
650	0	4	_aComplement Activation
650	0	4	_aComplement C3 Convertase, Alternative Pathway
650	0	4	_aComplement C3b _xbiosynthesis
650	0	4	_aComplement C4 _xbiosynthesis
650	0	4	_aComplement C4b
650	0	4	_aComplement Membrane Attack Complex _xbiosynthesis
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aFemale
650	0	4	_aHeart Rate
650	0	4	_aHemodynamics
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aKidney Transplantation _ximmunology
650	0	4	_aLung Transplantation _ximmunology
650	0	4	_aMale
650	0	4	_aMethylprednisolone _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aModels, Chemical
650	0	4	_aMuromonab-CD3 _xtherapeutic use
650	0	4	_aPeptide Fragments _xbiosynthesis
700	1		_aWilliams, W W
700	1		_aCosimi, A B
700	1		_aTolkoff-Rubin, N
700	1		_aGinns, L C
700	1		_aWain, J C
700	1		_aPreffer, F
700	1		_aOlszak, I
700	1		_aWee, S
700	1		_aDelmonico, F L
700	1		_aPascual, M
773	0		_tTransplantation _gvol. 67 _gno. 2 _gp. 253-8
856	4	0	_uhttps://doi.org/10.1097/00007890-199901270-00011 _zAvailable from publisher's website
999			_c10035535 _d10035535